about
Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious diseases{beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndromeEstimation of seroprevalence of the pandemic H1N1 2009 influenza virus using a novel virus-free ELISA assay for the detection of specific antibodies.Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women.Suspects in the tale of lupus-associated thrombocytopenia.A novel mechanism of thrombosis in antiphospholipid antibody syndrome.Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbitsAssessment of antibody responses in local and immigrant residents of areas with autochthonous malaria transmission in Greece.Origin, antigenic specificity and regulation of autoantibodies targeting Ro/La RNP.Unmasking the anti-La/SSB response in sera from patients with Sjogren's syndrome by specific blocking of anti-idiotypic antibodies to La/SSB antigenic determinantsDiscovery of Immunodominant B Cell Epitopes within Surface Pneumococcal Virulence Proteins in Pediatric Patients with Invasive Pneumococcal DiseaseAutoantibodies to intracellular autoantigens and their B-cell epitopes: molecular probes to study the autoimmune response.Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block.The role of chaperone proteins in autoimmunity.Autoimmune response and target autoantigens in Sjogren's syndrome.B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: tools to study the regulation of the autoimmune response.Autopathogenic correlation of periodontitis and rheumatoid arthritis.Functional expression of the alpha 2-macroglobulin receptor CD91 in salivary gland epithelial cells.Synthetic peptides for efficient discrimination of anti-enterovirus antibodies at the serotype level.Serologic prevalence of coxsackievirus group B in Greece.Cross-reaction between antibodies to the major epitope of Ro60 kD autoantigen and a homologous peptide of Coxsackie virus 2B protein.Study of the anti-idiotypic resonse to anti-LA/SSB autoantibodies using complementary peptides to B- and T-cell epitopes of La/SSB.Induction of immune responses in inbreed mice by immunizations with the complementary 289-308 La/SSB epitope.Zinc finger domain of Ro60kD autoantigen is essential for binding of Ro52kD and autoantibodies.In silico analysis and in vitro evaluation of immunogenic and immunomodulatory properties of promiscuous peptides derived from Leishmania infantum eukaryotic initiation factor.Evaluation of protective efficacy of selected immunodominant B-cell epitopes within virulent surface proteins of S. Pneumoniae.T cell help is required to induce idiotypic-anti-idiotypic autoantibody network after immunization with complementary epitope 289-308aa of La/SSB autoantigen in non-autoimmune mice.Expression of innate immune receptors in the immunopathologic lesion of primary Sjogren's syndrome: preliminary results.Greek rheumatoid arthritis patients have elevated levels of antibodies against antigens from Proteus mirabilis.Novel Protein-Based Pneumococcal Vaccines: Assessing the Use of Distinct Protein Fragments Instead of Full-Length Proteins as Vaccine AntigensAnalysis of parotid glands of primary Sjögren's syndrome patients using proteomic technology reveals altered autoantigen composition and novel antigenic targetsAnti-La/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspringPost-translational modifications of the major linear epitope 169-190aa of Ro60 kDa autoantigen alter the autoantibody bindingZinc ion dependent B-cell epitope, associated with primary Sjogren's syndrome, resides within the putative zinc finger domain of Ro60kD autoantigen: physical and immunologic propertiesAnti-CD40 antibodies in antiphospholipid syndrome and systemic lupus erythematosusCross-recognition between histones and La/SSB may account for anti-DNA reactivity in SLE patientsPeripheral neuropathies in Sjogren syndrome: a new reappraisalElevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseasesPreferential recognition of the phosphorylated major linear B-cell epitope of La/SSB 349-368 aa by anti-La/SSB autoantibodies from patients with systemic autoimmune diseasesFine epitope specificity of anti-erythropoietin antibodies reveals molecular mimicry with HIV-1 p17 protein: a pathogenetic mechanism for HIV-1-related anemia
P50
Q26863523-5379C235-2F22-4D42-A048-DB8CA77BF253Q28115185-BD0E9BED-8C8F-40E2-9A5D-ED9361D2BD98Q30403732-1150277D-6FF0-4800-8830-F6F7810DD294Q33199008-48856BD6-1EF9-44C2-93FD-40342F0D617CQ33371650-9EFB1A9F-8C00-4BF8-9366-AFE7834AA65AQ33390825-CB6B156A-1E87-4F9D-8E3A-E7BAF92411DAQ35015882-2D887820-53C9-4990-979F-BAF66014BB08Q35836613-FFE004F1-1E4C-4622-8C8A-DC259ABE3EA7Q35862444-3C591C0D-4DB4-48B7-8C49-86EC9A110793Q36088051-89C5443A-0D38-4DF2-B4C6-9BBBC45BCD61Q36282841-9CF1CC84-0030-4EC3-8CAE-7C135456243AQ36436250-1EE973B3-DCB8-4088-B313-708F237F0C45Q36551060-5E4C9F98-2DB4-4782-AE13-8052E9429D1AQ36693939-D73A75C7-01D0-4905-A756-384D660B1E9EQ37772540-738A4540-3E47-4D58-A887-7E54A0BA2A18Q37774110-E9D32A9D-F637-480D-829A-25393B9AF172Q37845987-F8487745-FCF4-46F4-A677-B6FCB732E678Q39821023-5130C2B3-C6F2-421E-86EB-E8F27A38028DQ42212537-404FB488-ECE3-450B-939B-208EF913AF0EQ44711362-D8E7900E-DADD-4F59-819C-4DE8BA391C5EQ45448319-8A97C1EC-C6A9-4120-B5CA-79D867FF0089Q45780899-4E080A40-42F0-4FB7-A243-E4DC0F5F9F6BQ46005006-6A8A3AB2-4FD5-44B4-8E40-DC2B5BA301ADQ46315166-D11F50BA-A1A8-420A-90BF-05A24C9181BBQ46445408-5D79EA38-7CA8-47D1-B090-FF518A9978BBQ47269510-2E46AF79-6FB1-4A4A-BBA3-85102593AC89Q47981648-C4BC20A4-CC56-47AF-886B-884FFB29E795Q50109149-2F86681C-53AF-4040-AA3A-B3FF7C81E364Q51410622-5A7F5850-E69E-49C0-BCFA-C0A58E1E4A5CQ64229705-91216789-74F6-4CDC-BF9C-D34657D570C4Q79440726-8FDCDE29-67C7-4632-91F5-1EDFA3847D2CQ79794989-7C80DE3F-C8C4-440B-9334-03CB99587171Q80249740-3E37B4CB-6C38-4B18-8BAD-DDBBED7D4B3BQ80417337-A5D570F2-3CBE-4D41-8D94-715B1BB92A19Q81105560-D492CE1B-4F9B-4CA2-BAE2-B3D4542627F8Q81249367-4BD8A95E-CB2C-4254-9BDC-DB820516653EQ82966736-DCA15267-48EC-4D29-BCFB-A9B368EEBDADQ83169050-E812BFF0-2B25-41D6-8CC1-0C2C55223089Q83874899-41735BE8-D55F-4E8D-91EF-F7CC5D0B21C4Q84782598-72AAC6AC-FFC1-4822-A892-7A9C949C2AEE
P50
description
Forscher
@de
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究員
@ja
研究者
@zh
name
John G Routsias
@en
John G Routsias
@nl
type
label
John G Routsias
@en
John G Routsias
@nl
prefLabel
John G Routsias
@en
John G Routsias
@nl
P106
P31
P496
0000-0002-5819-021X